Cepheid Industry Lunch Symposium
32nd International Congress of Antimicrobial Chemotherapy
Mon 28 Nov 2022 (12.00pm - 1.15pm)
THE CONTINUING CHALLENGE OF CARBAPENEM RESISTANCE GLOBALLY
Dr. Fred C. Tenover
Ph.D., D(ABMM), F(AAM), F(IDSA)
Dr. Tenover is Vice President of Scientific Affairs at Cepheid, Consulting Professor of Pathology at Stanford University School of Medicine, Adjunct Professor of Epidemiology in the Rollins School of Public Health at Emory University, and Consulting Professor of Biology at the University of Dayton. He joined the Centers for Disease Control and Prevention in Atlanta in 1990 and served for 18 years as Associate Director for Laboratory Science in the Division of Healthcare Quality Promotion and then as Director of the Office of Antimicrobial Resistance for CDC. He joined Cepheid in California in 2008 where he focused his research studies on carbapenem resistance and the epidemiology of Staphylococcus aureus and Clostridiodes difficile. He is a Diplomate of the American Board of Medical Microbiology and a Fellow of both the American Academy of Microbiology and the Infectious Disease Society of America. He has authored over 350 peer-reviewed journal articles and has written or edited 11 books.
Pfizer Hosted Evening Symposium
32nd International Congress of Antimicrobial Chemotherapy
Mon 28 Nov 2022 (7.00pm - 9.30pm)
COVID-19: GLOBAL LESSONS LEARNED FROM THE PANDEMIC
Professor Joseph Blondeau
Head of Clinical Microbiology
Royal University Hospital, Saskatchewan Health Authority
University of Saskatchewan
SASKATOON,CANADA
Doctor Jennifer Coetzee
Senior Consultant Microbiologist
Clinical Microbiology and Molecular Biology Department
Ampath National Reference Laboratory
PRETORIA, SOUTH AFRICA
Professor Matthew Dryden
Consultant in Infection and Microbiology
Royal Hampshire County Hospital
University of Southampton
WINCHESTER, UNITED KINGDOM
Professor Mahmoud Ghannoum
Professor and Director, Center for Medical Mycology
University Hospitals Cleveland Medical Center
Case Western Reserve University
CLEVELAND, UNITED STATES
Professor Souha Kanj
Professor of Medicine and Head of Division of Infectious Diseases
Associate Dean for Global Affairs
American University of Beirut Medical Center
BEIRUT, LEBANON
Doctor David Grolman
Cluster Medical Lead
Pfizer Hospital Medical Affairs
APAC Developed Markets - Australia, New Zealand & Korea
SYDNEY AUSTRALIA
| TIME | PRESENTATION | SPEAKER |
| 7.00pm | Welcome and Introduction Entrée Served | Doctor DAVID GROLMAN |
| 7.10pm | Rising to the challenge: The impact of COVID-19 on diagnostic clinical microbiology laboratories | Professor JOSEPH BLONDEAU |
| 7.30pm | Managing the vulnerable infected patient in an era of MDR pathogens | Professor MATTHEW DRYDEN |
| 7.50pm | Promiscuous plasmids: The emergence of NDM & OXA-48 co-producing Klebsiella pneumoniae during the COVID-19 pandemic | Doctor Jennifer Coetzee |
| 8.10pm | Dinner Served | |
| 8.20pm | COVID-associated Pulmonary Aspergillosis and the global emergence of other mould pathogens during the pandemic | Professor MAHMOUD GHANNOUM |
| 8.40pm | Antimicrobial stewardship challenges that emerged during the COVID-19 pandemic and proposed solutions | Professor SOUHA KANJ |
| 9.00pm | Ask-the-Expert: Audience Questions and Answers Session | ALL SPEAKERS |
| 9.30pm | Meeting Close |
Lunch Symposium Sponsored by Gilead
32nd International Congress of Antimicrobial Chemotherapy
Tue 29 Nov 2022 (12.00pm - 1.15pm)
INVASIVE FUNGAL INFECTIONS IN THE ICU - THE IMPORTANCE OF EARLY DETECTION AND ACTION
ICMS Pty Ltd
(+61) 3 9810 0200
32icc@icms.com.au
icms.com.au
© Copyright 2022 - 32nd International Congress of Antimicrobial Chemotherapy (ICC)